Correlation Between Kura Oncology and Kalvista Pharmaceuticals

Can any of the company-specific risk be diversified away by investing in both Kura Oncology and Kalvista Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kura Oncology and Kalvista Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Kura Oncology and Kalvista Pharmaceuticals, you can compare the effects of market volatilities on Kura Oncology and Kalvista Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kura Oncology with a short position of Kalvista Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kura Oncology and Kalvista Pharmaceuticals.

Diversification Opportunities for Kura Oncology and Kalvista Pharmaceuticals

0.45

Correlation Coefficient

Kura Oncology  Kalvista Pharmaceuticals

Very weak diversification

The 3 months correlation between Kura and Kalvista is 0.45. Overlapping area represents the amount of risk that can be diversified away by holding Kura Oncology and Kalvista Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Kalvista Pharmaceuticals and Kura Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kura Oncology are associated (or correlated) with Kalvista Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Kalvista Pharmaceuticals has no effect on the direction of Kura Oncology i.e., Kura Oncology and Kalvista Pharmaceuticals go up and down completely randomly.

Pair Corralation between Kura Oncology and Kalvista Pharmaceuticals

Given the investment horizon of 90 days Kura Oncology is expected to under-perform the Kalvista Pharmaceuticals. In addition to that, Kura Oncology is 1.1 times more volatile than Kalvista Pharmaceuticals. It trades about -0.15 of its total potential returns per unit of risk. Kalvista Pharmaceuticals is currently generating about -0.05 per unit of volatility. If you would invest  1,237  in Kalvista Pharmaceuticals on September 2, 2024 and sell it today you would lose (231.00) from holding Kalvista Pharmaceuticals or give up 18.67% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Kura Oncology  vs.  Kalvista Pharmaceuticals

Kura Oncology

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Kura Oncology has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Kalvista Pharmaceuticals

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Kalvista Pharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's essential indicators remain fairly stable which may send shares a bit higher in January 2025. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.

Pair Trading with Kura Oncology and Kalvista Pharmaceuticals

The main advantage of trading using opposite Kura Oncology and Kalvista Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kura Oncology position performs unexpectedly, Kalvista Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kalvista Pharmaceuticals will offset losses from the drop in Kalvista Pharmaceuticals' long position.

The idea behind Kura Oncology and Kalvista Pharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Economic Indicators module to top statistical indicators that provide insights into how an economy is performing.